Annual long term liabilities:
$630.00K-$306.00K(-32.69%)Summary
- As of today (May 29, 2025), VKTX annual total long term liabilities is $630.00 thousand, with the most recent change of -$306.00 thousand (-32.69%) on December 31, 2024.
- During the last 3 years, VKTX annual long term liabilities has risen by +$630.00 thousand (+100.00%).
- VKTX annual long term liabilities is now -86.70% below its all-time high of $4.74 million, reached on December 31, 2015.
Performance
VKTX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$502.00K-$128.00K(-20.32%)Summary
- As of today (May 29, 2025), VKTX quarterly total long term liabilities is $502.00 thousand, with the most recent change of -$128.00 thousand (-20.32%) on March 31, 2025.
- Over the past year, VKTX quarterly long term liabilities has dropped by -$350.00 thousand (-41.08%).
- VKTX quarterly long term liabilities is now -90.10% below its all-time high of $5.07 million, reached on March 31, 2016.
Performance
VKTX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VKTX Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -32.7% | -41.1% |
3 y3 years | +100.0% | -66.3% |
5 y5 years | +75.0% | +79.9% |
VKTX Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -50.0% | >+9999.0% | -66.3% | at low |
5 y | 5-year | -50.0% | >+9999.0% | -66.3% | >+9999.0% |
alltime | all time | -86.7% | >+9999.0% | -90.1% | >+9999.0% |
VKTX Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $502.00K(-20.3%) |
Dec 2024 | $630.00K(-32.7%) | $630.00K(-16.6%) |
Sep 2024 | - | $755.00K(-1.4%) |
Jun 2024 | - | $766.00K(-10.1%) |
Mar 2024 | - | $852.00K(-9.0%) |
Dec 2023 | $936.00K(-25.7%) | $936.00K(-8.1%) |
Sep 2023 | - | $1.02M(-7.5%) |
Jun 2023 | - | $1.10M(-6.9%) |
Mar 2023 | - | $1.18M(-6.3%) |
Dec 2022 | $1.26M(>+9900.0%) | $1.26M(-5.8%) |
Sep 2022 | - | $1.34M(-5.4%) |
Jun 2022 | - | $1.41M(-5.1%) |
Mar 2022 | - | $1.49M(>+9900.0%) |
Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2021 | - | $0.00(0.0%) |
Jun 2021 | - | $0.00(0.0%) |
Mar 2021 | - | $0.00(-100.0%) |
Dec 2020 | $29.00K(-91.9%) | $29.00K(-74.8%) |
Sep 2020 | - | $115.00K(-41.9%) |
Jun 2020 | - | $198.00K(-29.0%) |
Mar 2020 | - | $279.00K(-22.5%) |
Dec 2019 | $360.00K | $360.00K(-17.8%) |
Sep 2019 | - | $438.00K(-14.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $513.00K(-12.8%) |
Mar 2019 | - | $588.00K(+4800.0%) |
Dec 2018 | $12.00K(>+9900.0%) | $12.00K(>+9900.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(-100.0%) |
Jun 2017 | - | $6100.00(-99.9%) |
Mar 2017 | - | $4.22M(>+9900.0%) |
Dec 2016 | $16.30K(-99.7%) | $16.30K(-20.5%) |
Sep 2016 | - | $20.50K(-16.7%) |
Jun 2016 | - | $24.60K(-99.5%) |
Mar 2016 | - | $5.07M(+7.0%) |
Dec 2015 | $4.74M(+78.5%) | $4.74M(>+9900.0%) |
Sep 2015 | - | $19.10K(>+9900.0%) |
Jun 2015 | - | $0.00(-100.0%) |
Mar 2015 | - | $2.90M(+9.2%) |
Dec 2014 | $2.65M(+774.7%) | $2.65M(+103.6%) |
Jun 2014 | - | $1.30M(+308.5%) |
Mar 2014 | - | $319.10K |
Dec 2013 | $303.50K(+495.1%) | - |
Dec 2012 | $51.00K | - |
FAQ
- What is Viking Therapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual long term liabilities year-on-year change?
- What is Viking Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly long term liabilities year-on-year change?
What is Viking Therapeutics annual total long term liabilities?
The current annual long term liabilities of VKTX is $630.00K
What is the all time high annual long term liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total long term liabilities is $4.74M
What is Viking Therapeutics annual long term liabilities year-on-year change?
Over the past year, VKTX annual total long term liabilities has changed by -$306.00K (-32.69%)
What is Viking Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VKTX is $502.00K
What is the all time high quarterly long term liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total long term liabilities is $5.07M
What is Viking Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VKTX quarterly total long term liabilities has changed by -$350.00K (-41.08%)